Evidence map›Paper›PMID 32423239›Full record

ArticleJournal of child and adolescent psychopharmacology2020

Lenard A Adler, Brigitte Robertson, Jie Chen, Elias Sarkis

Open access · hybridAbstract read
In one paragraph

Article in Journal of child and adolescent psychopharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Lenard A AdlerDepartment of Psychiatry and NYU Langone Medical Center, New York, New York, USA.
Brigitte RobertsonGlobal Clinical Development, Shire, a member of the Takeda group of companies, Lexington, Massachusetts, USA.
Jie ChenBiostatistics, Shire, a member of the Takeda group of companies, Lexington, Massachusetts, USA.
Elias SarkisSarkis Family Psychiatry, Gainesville, Florida, USA.
Takeda (United States) · USNYU Langone Health · USUniversity of Florida · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Dose-Response Relationship, DrugAdultAmphetaminesAttention Deficit Disorder with HyperactivityCentral Nervous System StimulantsDelayed-Action PreparationsFemaleHumansMalePsychiatric Status Rating ScalesAmphetaminesCentral Nervous System StimulantsDelayed-Action Preparationsadultattention-deficit/hyperactivity disorder (ADHD)remissionresponseSHP465 mixed amphetamine salts (SHP465 MAS)

Identifiers

PMID32423239
PMCPMC7475095
OpenAlexW3026395075

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.